Another mechanism of PARPi resistance in BRCA1/2-deficient tumor cells is due to the downregulation of PARP1 expression, thereby resulting in PARylation-independent cell proliferation and/or the inefficiency of PARP1 trapping by PARPi. The gene discussed is PARP1; the disease is neoplasm.